Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prothena Corp PLC

6.88
-0.0500-0.72%
Post-market: 6.880.00000.00%18:12 EDT
Volume:1.24M
Turnover:8.76M
Market Cap:370.33M
PE:-3.36
High:7.33
Open:7.00
Low:6.74
Close:6.93
Loading ...

Prothena Corp Q1 EPS $(1.12) Misses $(0.97) Estimate, Sales $2.83M Miss $8.05M Estimate

Benzinga
·
09 May

Prothena Reports Q1 2025 Results: Revenue Surges to $2.8M, Net Loss Narrows to $60.2M, EPS at $1.12

Reuters
·
09 May

BRIEF-Prothena Q1 Net Income USD -60.195 Million Vs. IBES Estimate USD -52.7 Million

Reuters
·
09 May

Prothena Corporation PLC expected to post a loss of 97 cents a share - Earnings Preview

Reuters
·
07 May

Prothena Corporation plc Files Initial Statement of Beneficial Ownership for William P. Scully

Reuters
·
02 May

Press Release: Prothena to Report First Quarter 2025 Financial Results on May 8

Dow Jones
·
02 May

Prothena Is Maintained at Overweight by Piper Sandler

Dow Jones
·
27 Feb

Piper Sandler Keeps Their Buy Rating on Prothena (PRTA)

TIPRANKS
·
26 Feb

Analysts Are Bullish on Top Healthcare Stocks: Prothena (PRTA), Dexcom (DXCM)

TIPRANKS
·
23 Feb

Prothena Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
22 Feb

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

Zacks
·
22 Feb

Stock Track | Prothena Stock Soars 6.1% on Positive Earnings Outlook and Pipeline Progress

Stock Track
·
21 Feb

Prothena Price Target Maintained With a $48.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Feb

RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
21 Feb

Prothena Is Maintained at Buy by Chardan Capital

Dow Jones
·
21 Feb

Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...

GuruFocus.com
·
21 Feb

JMP Securities Keeps Their Buy Rating on Prothena (PRTA)

TIPRANKS
·
21 Feb

Prothena Corporation PLC expected to post a loss of $1.04 a share - Earnings Preview

Reuters
·
19 Feb

Further weakness as Prothena (NASDAQ:PRTA) drops 16% this week, taking three-year losses to 61%

Simply Wall St.
·
04 Feb

Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug

Zacks
·
03 Feb